Literature DB >> 8052489

Extrahepatic primary malignant neoplasms associated with hepatocellular carcinoma: high occurrence of B cell tumors.

M Di Stasi1, G Sbolli, F Fornari, L Cavanna, S Rossi, E Buscarini, G Civardi, D Vallisa, R Berté, L Buscarini.   

Abstract

In a consecutive series of 317 patients with hepatocellular carcinoma (HCC), 32 (10.1%) had 35 extrahepatic primary malignant neoplasms (PMNs) (3 patients had triple cancers). Twenty-five PMNs occurred before the diagnosis of HCC, 7 were synchronous and 3 metachronous. These 35 PMNs were: 6 cancers of the colon, 3 of the stomach, 1 of the rectum, 4 of the breast, 2 of the lung, 1 of the larynx, 3 of the prostate, 1 of the penis, 1 of the urinary bladder, 1 of the uterus, 2 of the skin, and the remaining 10 were immunoproliferative cancers, all of B cell origin (7 non-Hodgkin's lymphoma, 2 multiple myeloma, and 1 chronic lymphocytic leukemia). Thus, in this series, B-lymphocyte-derived neoplasms were the most frequent PMNs associated with HCC. These 10 patients showed no difference for age, male:female ratio, HCC cytotype, presence of cirrhosis, alcohol abuse, markers related to hepatitis B and C virus, and serum level of alpha-fetoprotein when compared with the 22 patients with HCC and other PMNs and the 285 with HCC alone. B cell neoplasms constitute half of the synchronous or metachronous cancers, and must, therefore, be kept in mind in the management of HCC patients.

Entities:  

Mesh:

Year:  1994        PMID: 8052489     DOI: 10.1159/000227383

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  8 in total

1.  Malignant lymphoma of the stomach after chemotherapy for hepatocellular carcinoma.

Authors:  I Matsuo; K Omagari; N Ikuno; H Kinoshita; Y Onizuka; M Itsuno; T Nakayama; S Kohno
Journal:  J Gastroenterol       Date:  1997-08       Impact factor: 7.527

Review 2.  Familial heterozygous hypobetalipoproteinemia, extrahepatic primary malignancy, and hepatocellular carcinoma.

Authors:  A Lonardo; P Tarugi; G Ballarini; A Bagni
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

3.  Hepatocellular carcinoma in a patient with chronic lymphocytic leukaemia involving the liver.

Authors:  Chika Ezigbo; Alexander M Sy; Andrea Popescu-Martinez; Noella Boma; Nora V Bergasa
Journal:  BMJ Case Rep       Date:  2014-09-30

4.  Autopsy case of colocalized tumors of hepatocellular carcinoma and malignant lymphoma.

Authors:  S Shikuwa; M Ito; M Nakashima; K Hamasaki; S Naito; I Sekine; H Fujii
Journal:  J Gastroenterol       Date:  1996-02       Impact factor: 7.527

5.  Prevalence and outcomes of extrahepatic primary malignancy associated with hepatocellular carcinoma in a Korean population.

Authors:  Sukho Hong; Sook-Hyang Jeong; Sang Soo Lee; Jung Wha Chung; Sung Wook Yang; Seong Min Chung; Eun Sun Jang; Jin-Wook Kim; Jee Hyun Kim; Haeryoung Kim; Jai Young Cho; Yoo-Seok Yoon; Ho-Seong Han
Journal:  BMC Cancer       Date:  2015-03-18       Impact factor: 4.430

6.  Second primary cancers following non-Hodgkin's lymphoma in Japan: increased risk of hepatocellular carcinoma.

Authors:  H Tanaka; H Tsukuma; H Teshima; W Ajiki; Y Koyama; N Kinoshita; T Masaoka; A Oshima
Journal:  Jpn J Cancer Res       Date:  1997-06

7.  Analysis of Extrahepatic Multiple Primary Malignancies in Patients with Hepatocellular Carcinoma according to Viral Infection Status.

Authors:  Keita Kai; Atsushi Miyoshi; Kenji Kitahara; Masanori Masuda; Yukari Takase; Kohji Miyazaki; Hirokazu Noshiro; Osamu Tokunaga
Journal:  Int J Hepatol       Date:  2012-12-01

8.  Hepatocellular Carcinoma associated with Extra-hepatic Primary Malignancy: its Secular change, Clinical Manifestations and Survival.

Authors:  Kwong Ming Kee; Jing-Houng Wang; Chih-Chi Wang; Yu-Fan Cheng; Sheng-Nan Lu
Journal:  Sci Rep       Date:  2016-07-22       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.